Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes: The NOAH-AFNET 6 Trial

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes: The NOAH-AFNET 6 Trial

According to the NOAH-AFNET 6 trial, anticoagulation with edoxaban did not prevent cardiovascular death/stroke/ and systemic embolism in patients with atrial high-rate episodes (AHRE) detected by an implantable cardiac device. Dr. Paulus Kirchhof of University Heart and Vascular Center Hamburg, Germany, and colleagues reported in the September 28 issue of The New England Journal of Medicine.

AHRE is an atrial arrhythmia detected by an implantable cardiac device and resembles atrial fibrilla...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
NEJM
Complete Revascularization vs. Responsible Lesion Only PCI in Elderly MI Patients: The FIRE Trial
Complete Revascularization vs. Responsible Lesion Only PCI in Elderly MI Patients: The FIRE Trial
NEJM
Endovascular treatment in acute ischemic stroke patients with extensive infarction: the ANGEL-ASPECT trial
Endovascular treatment in acute ischemic stroke patients with extensive infarction: the ANGEL-ASPECT trial
NEJM
Transcatheter edge-to-edge repair in patients with tricuspid regurgitation: the TRILUMINATE trial
Transcatheter edge-to-edge repair in patients with tricuspid regurgitation: the TRILUMINATE trial
NEJM
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Optimal IVUS-Guided LM-PCI: The OPTIVUS-Complex PCI Study LMCA Cohort
AJC
Optimal IVUS-Guided LM-PCI: The OPTIVUS-Complex PCI Study LMCA Cohort
Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials
Circ Intervention
Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials
Predictors of Cardiovascular Events After Coronary IVL Use: The BENELUX-IVL Registry
AJC
Predictors of Cardiovascular Events After Coronary IVL Use: The BENELUX-IVL Registry
Orbital Atherectomy vs Balloon-Based Vessel Preparation for Severely Calcified Coronary Lesions: The ECLIPSE OCT Substudy
Circ Intervention
Orbital Atherectomy vs Balloon-Based Vessel Preparation for Severely Calcified Coronary Lesions: The ECLIPSE OCT Substudy